Magrolimab Falls Off The Fast Track As Gilead Reveals New Clinical Holds

Biktarvy Settlement Totals $1.25bn Up Front, 3% US Bictegravir Royalty

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.